People are underestimating the significance of drug pricing provisions in Inflation Reduction Act
Rena Conti, Leslie Dach and Richard Frank, Opinion Article The Hill, October 6, 2023.
Category: In the News
Bipartisan battle over prescription intermediaries heats up
Rena Conti, TPRI Faculty Director, quoted in The Hill, 09/28/23
Second House Oversight Hearing Shines a Harsh Light on PBM Practices
Rena Conti, TPRI Faculty Director, quoted in Pharmacy Practice News, 09/19/23
Want to Find the Next Big Company? IP Offers a Clue.
Timothy Simcoe, TPRI Faculty Director and Filippo Mezzanotti’s research cited in Kellogg Insight, Kellogg School of Management, Northwestern University, August 3, 2023.
Tornado damage to Pfizer factory highlights vulnerabilities of drug supply
Rena Conti, TPRI Faculty Director, quoted in NPR, July 27, 2023
Big Tech’s Battle Royale Is Coming. The Winner? You
James Bessen, TPRI’s Executive Director, quoted in The Wall Street Journal, June 29, 2023
Will a Noncompete Ban Impact Innovation Beyond Tech Hubs?
Timothy Simcoe, TPRI Faculty Director, quoted in the MIT Sloan Management Review, June 28, 2023.
Should Companies Refrain From Making Political Statements?
Timothy Simcoe, TPRI Faculty Director, quoted in the
MIT Sloan Management Review, May 31, 2023.
Munk Dialogue with James Bessen: how AI will transform the labour market
James Bessen, TPRI’s Executive Director, was interviewed on
Munk Debates Podcast, June 19, 2023
Mark Cuban’s Pharmacy Adds Another Onc Drug: Capecitabine
Rena Conti, TPRI Faculty Director, quoted in Medscape, May 26, 2023.